1. 134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension Study. (April 2020) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Forrest Gordon, Mark; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study. (April 2020) Authors: Fernandez, Hubert H.; Barkay, Hadas; Hauser, Robert A.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents. (April 2020) Authors: Jankovic, Joseph; Coffey, Barbara; Claassen, Daniel O.; Stamler, David; Gertz, Barry J.; Garofalo, Elisabeth A.; Wieman, Maria; Gordon, Mark Forrest; Savola, Juha-Matti Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimod. Issue 2 (3rd April 2023) Authors: Roussakis, Andreas-Antonios; Gennaro, Marta; Gordon, Mark Forrest; Reilmann, Ralf; Borowsky, Beth; Rynkowski, Gail; Lao-Kaim, Nicholas P; Papoutsou, Zoe; Savola, Juha-Matti; Hayden, Michael R; Owen, David R; Kalk, Nicola; Lingford-Hughes, Anne; Gunn, Roger N; Searle, Graham; Tabrizi, Sarah J; Pic... Journal: Brain communications Issue: Volume 5:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of Safety and Tolerability of Deutetrabenazine During Titration and Maintenance in Patients with Tardive Dyskinesia. (April 2021) Authors: Wilhelm, Amanda; Anderson, Karen E.; Fernandez, Hubert H.; Barkay, Hadas; Chaijale, Nayla; Send, Alexander F.; Savola, Juha-Matti; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia. (April 2021) Authors: Jimenez-Shahed, Joohi; Barkay, Hadas; Anderson, Karen E.; Fernandez, Hubert H.; Factor, Stewart A.; Hauser, Robert A.; Wieman, Maria; Gordon, Mark Forrest; Savola, Juha-Matti Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders. (April 2022) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease. (April 2021) Authors: Frank, Samuel; Vaughan, Christina; Stamler, David; Oakes, David; Davis, Mat D.; Gross, Nicholas; Gordon, Mark Forrest; Savola, Juha-Matti; Wieman, Maria; Eberly, Shirley; Kayson, Elise; Whaley, Jacquelyn; Goldstein, Jody; Testa, Claudia M. Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study. (April 2021) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington's Disease: Results From the ARC-HD Open-label Study. (April 2021) Authors: Frank, Samuel; Testa, Claudia M.; Stamler, David; Kayson, Elise; Oakes, David; Vaughan, Christina; Goldstein, Jody; Whaley, Jacquelyn; Davis, Mat D.; Gordon, Mark Forrest; Savola, Juha-Matti Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗